logo LinfoNeo

In breast cancer patients with axillary involvement at presentation, neoadjuvant chemotherapy may downstage axillary disease.
Type of axillary surgery in patients who convert from cN+ to ycN0 after neoadjuvant chemotherapy is still debated.

11 European Breast Units developed and validated a preoperative predictive nomogram to select those patients with a low risk of residual axillary disease after neoadjuvant chemotherapy, in whom axillary surgery could be minimized.

This score system is a useful tool to predict nodal pCR after neoadjuvant chemotherapy, translating the concept of tailored axillary surgery also in this setting of patients.

Download Now
screenshot

In collaboration with:

Breast Unit, Department of Surgery, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy

Chirurgia Generale, Ospedale Centrale di Bolzano, Azienda Sanitaria dell'Alto Adige, Italy

Breast Unit, Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

SSD Breast Unit, ASST-Settelaghi di Varese, Italy

Breast Unit Azienda Ospedaliero-Universitaria Policlinico Modena, Italy

Chirurgia Senologica, Ospedale Morgagni Pierantoni, Ausl Romagna, Forlì, Italy

Breast Surgery, Department of Surgery, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Breast Surgery Unit, AUSL-IRCCS Reggio Emilia, Italy

Service of Gynecology and Obstetrics, Department of Gynecology and Obstetrics, Ospedale Regionale di Lugano EOC, Lugano, Switzerland

Breast Surgery, San Raffaele University and Research Hospital, Milano Italy

Breast Cancer Centre, University Hospital of Pisa, Italy

Breast Surgery, Department of Surgery, ASST Fatebenefratelli Sacco - Milano, Italy